1. Home
  2. SY vs RNA Comparison

SY vs RNA Comparison

Compare SY & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SY

So-Young International Inc. American Depository Shares

HOLD

Current Price

$2.16

Market Cap

192.7M

Sector

Technology

ML Signal

HOLD

Logo Avidity Biosciences Inc.

RNA

Avidity Biosciences Inc.

HOLD

Current Price

$12.21

Market Cap

222.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SY
RNA
Founded
2013
2012
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
192.7M
222.5M
IPO Year
2018
2025

Fundamental Metrics

Financial Performance
Metric
SY
RNA
Price
$2.16
$12.21
Analyst Decision
Strong Buy
Buy
Analyst Count
1
20
Target Price
$5.50
$69.26
AVG Volume (30 Days)
205.3K
127.8K
Earning Date
05-15-2026
01-01-0001
Dividend Yield
0.91%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$38.64
$88.12
Revenue Next Year
$30.63
$18.11
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.28
$11.13
52 Week High
$5.35
$73.06

Technical Indicators

Market Signals
Indicator
SY
RNA
Relative Strength Index (RSI) 64.48 51.20
Support Level $1.68 $11.95
Resistance Level $2.15 $14.05
Average True Range (ATR) 0.16 0.39
MACD 0.03 0.05
Stochastic Oscillator 80.46 80.33

Price Performance

Historical Comparison
SY
RNA

About SY So-Young International Inc. American Depository Shares

So-Young International Inc is an aesthetic treatment platform in China connecting consumers with online services and offline treatments. Its online platform operates across multiple access points, including mobile app, Weixin mini program, and soyoung.com website, where both consumers and aesthetic practitioners can access media content, an engaging social community and a transparent reservation system. The company has four reportable segments: Aesthetic treatment services group, Platform service group, Wuhan Miracle, and Others. The majority of revenue is derived from the Platform service group, which generates revenue by providing information services and reservation services. All the company's revenues are derived from within the PRC.

About RNA Avidity Biosciences Inc.

Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.

Share on Social Networks: